Forma Therapeutics Holdings, Inc.,
SEC CIK 1538927 · FTMX · last insider filing 2022-10-14
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Wirth Peter | Director | filed 2020 - 2022 |
| Wiggans Thomas G | Director | filed 2020 - 2022 |
| Clackson Timothy P | Director | filed 2020 - 2022 |
| Fanucci Marsha | Director | filed 2020 - 2022 |
| RA Capital Healthcare Fund LP | Director | filed 2020 - 2022 |
| RA Capital Management, LLC | Director | filed 2020 - 2022 |
| Kolchinsky Peter | Director | filed 2020 - 2022 |
| Molina Arturo MD | Director | filed 2022 - 2022 |
| Shah Rajeev M. | Director | filed 2020 - 2022 |
| Frederick Wayne A.I. | Director | filed 2020 - 2022 |
| Lee Frank D. | Director · President and CEO | filed 2020 - 2022 |
| Vickers Selwyn M MD | Director | filed 2021 - 2022 |
| Hall Steven Edward | Director | filed 2020 - 2020 |
| Paoletti Paolo | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bishop John E | SVP, Chief Technology Officer | filed 2021 - 2022 |
| Shegog Todd | SVP, Chief Financial Officer | filed 2020 - 2022 |
| Potts Jeannette | See Remarks | filed 2020 - 2022 |
| Melian Agustin | EVP, Research & Development | filed 2022 - 2022 |
| Lesser Brian Andrew | SVP, Commercial Officer | filed 2021 - 2022 |
| Kelly Patrick F. | SVP, Chief Medical Officer | filed 2020 - 2022 |
| Cook David N | SVP, Chief Scientific Officer | filed 2020 - 2022 |
| Wadlinger Mary E. | See Remarks | filed 2020 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.